Transcatheter Aortic Valve Replacement Market Size, Share, Revenue, Trends And Drivers For 2024-2033

Overview and Scope
Transcatheter aortic valve replacement (TAVR), also known as transcatheter aortic valve implantation (TAVI), is a minimally invasive medical procedure used to replace a diseased or malfunctioning aortic valve in the heart. It can be performed on adults who are not in good enough health to undergo standard valve surgery.

Sizing and Forecast
The transcatheter aortic valve replacement market size has grown rapidly in recent years. It will grow from $4.63 billion in 2023 to $5.32 billion in 2024 at a compound annual growth rate (CAGR) of 14.8%. The growth in the historic period can be attributed to rising prevalence of aortic regurgitation, rising prevalence of cardiovascular diseases, increasing patient preference for minimally invasive therapies, global expansion of tavr procedures, favorable reimbursement policies..

The transcatheter aortic valve replacement market size is expected to see rapid growth in the next few years. It will grow to $8.79 billion in 2028 at a compound annual growth rate (CAGR) of 13.4%. The growth in the forecast period can be attributed to increasing prevalence of aortic stenosis, growing adoption of minimally invasive procedures, expansion of indications for tavr procedures, favorable reimbursement policies, rising awareness of tavr as a viable treatment avenue. Major trends in the forecast period include continuous evolution of device technology, rising prevalence of cardiovascular diseases, global expansion of tavr procedures, aging demographic, rising healthcare expenditure..

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/transcatheter-aortic-valve-replacement-global-market-report

Segmentation & Regional Insights

The transcatheter aortic valve replacement market covered in this report is segmented –

1) By Product: Self-Expandable Transcatheter Aortic Valves, Balloon-Expandable Transcatheter Aortic Valves, Mechanically Expanded Transcatheter Aortic Valves
2) By Material: Valve Frame Material, Valve Leaflet Material
3) By Procedure: Transfemoral Implantation, Transapical Implantation, Transaortic Implantation
4) By Application: Aortic Stenosis, Aortic Regurgitation, Other Applications
5) By End-User: Hospitals, Independent Cardiac Catheterization Labs, Ambulatory Surgical Centers, Other End-Users

North America was the largest region in the transcatheter aortic valve replacement market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transcatheter aortic valve replacement market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12031&type=smp

Major Driver Impacting Market Growth
The increase in the prevalence of aortic stenosis is one of the driving factors for the transcatheter aortic valve replacement market going forward. Aortic stenosis is a medical condition that refers to the narrowing the aortic valve in the heart. It can be treated with transcatheter aortic valve replacement (TAVR), a less invasive alternative to surgical aortic valve replacement (SAVR) that aid in restoring blood flow and reducing the signs and symptoms of aortic valve stenosis. For instance, in August 2021, according to the report published by the Baker Heart and Diabetes Institute, an Australia-based research institute, 500,000 and 600,000 Australians in 2021 were suffering from heart valve disease. Further, Aortic stenosis cases are expected to rise to 200,000 in 2031 and 266,000 in 2051, respectively. Therefore, the increase in the prevalence of aortic stenosis is driving the transcatheter aortic valve replacement market.

Key Industry Players
Major companies operating in the transcatheter aortic valve replacement market report are Abbott Laboratories Inc., Medtronic plc, Boston Scientific Corporation, Hilton Worldwide Holdings Inc, Edwards Lifesciences Corporation, Bracco Group, LivaNova PLC, CryoLife Inc., Meril Life Sciences Pvt. Ltd., Venus MedTech HangZhou Inc, Braile Biomedica, Sorin Group USA Inc., Peijia Medical Limited, Direct Flow Medical Inc., Transcatheter Technologies GmbH, Symetis SA, JenaValve Technology Inc., Micro Interventional Devices Inc., Xeltis BV, Tendyne Holdings Inc., MVRx Inc., Keystone Heart Ltd., Colibri Heart Valve LLC, HighLife SAS, Neovasc Inc., St. Jude Medical Inc., Aegis Surgical Limited, Foldax Inc., MValve Technologies Ltd., NaviGate Cardiac Structures Inc.

The transcatheter aortic valve replacement market report table of contents includes:
1. Executive Summary
2. Transcatheter Aortic Valve Replacement Market Characteristics
3. Transcatheter Aortic Valve Replacement Market Trends And Strategies
4. Transcatheter Aortic Valve Replacement Market - Macro Economic Scenario
5. Global Transcatheter Aortic Valve Replacement Market Size and Growth
……….

32. Global Transcatheter Aortic Valve Replacement Market Competitive Benchmarking
33. Global Transcatheter Aortic Valve Replacement Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Transcatheter Aortic Valve Replacement Market
35. Transcatheter Aortic Valve Replacement Market Future Outlook and Potential Analysis
36. Appendix

Explore the trending research reports from TBRC:
https://topprnews.com/biopharmaceutical-fermentation-systems-market-forecast/
https://topprnews.com/chronic-wound-care-market-outlook/
https://topprnews.com/digital-audio-workstation-daw-software-market-trends/
https://goodprnews.com/biopharmaceutical-fermentation-systems-market-analysis/
https://goodprnews.com/chronic-wound-care-market-growth/
https://goodprnews.com/digital-audio-workstation-daw-software-market-forecast/